Results

eNauka >  Rezultati >  Patient (pt) preference and satisfaction with the subcutaneous fixed-dose combination of pertuzumab (P) and trastuzumab (H) in pts with HER2-positive early breast cancer (HER2+eBC): Interim analysis of the open-label, randomised cross-over PHranceSCa study
Naziv: Patient (pt) preference and satisfaction with the subcutaneous fixed-dose combination of pertuzumab (P) and trastuzumab (H) in pts with HER2-positive early breast cancer (HER2+eBC): Interim analysis of the open-label, randomised cross-over PHranceSCa study
Autori O'Shaughnessy, Joyce; ...; Cvetanovic, Ana S; ...; Stamatovic, Ljiljana
Godina: 2020
Publikacija: ANNALS OF ONCOLOGY
ISSN: 0923-7534 Annals of Oncology Pretraži identifikator
Tip rezultata: Konferencijski rad
Kolacija: vol. 31 str. S42-S42
DOI: 10.1016/j.annonc.2020.03.020
WoS-ID: 000538879300072
URI: https://enauka.gov.rs/handle/123456789/934004
Projekat: F. Hoffman-La Roche
Izvor metapodataka: (Preuzeto iz Nasi u WoS)
M-kategorija: 
Mp kategorija će biti prikazana naknadno.

1
OpenCitations
2
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.